The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells - Chen, Yulu; Sang, Ye; Li, Shiyong; Xue, Junyu; Chen, Mengke; Hong, Shubin; Lv, Weiming; Sehgal, Kartik; Xiao, Haipeng; Liu, Rengyun (Translational oncology, 2024)
Keywords: BRAF mutation; Cell cycle; ERK inhibitor; Original Research; Targeted therapy; ERK inhibitor; Targeted therapy; Cell cycle; BRAF mutation